All News

    PDS0101 Plus Keytruda Elicits Survival Response in Head and Neck Cancer

    August 27th 2025, 4:00pm

    Article

    In HPV15-positive first-line recurrent and/or metastatic head and neck cancer, PDS0101 and Keytruda elicited median overall survival more than three years.

    What Does Gastrointestinal Cancer Mean?

    August 27th 2025, 3:00pm

    Article

    Here is a primer on what patients who have received a diagnosis of gastrointestinal cancer need to know.

    AI Tools Speed Prostate Cancer Decisions With Faster Results

    August 27th 2025, 1:00pm

    Video

    FDA-authorized AI tools have the potential to help patients with prostate cancer get clearer answers instead of waiting weeks for genomic test results.

    How Can We Stand Up to Cancer as Patients?

    August 26th 2025, 9:00pm

    Article

    I share practical strategies for living well with cancer, from research and self-care to support, creativity, and wise giving.

    How Risk Status Can Affect Breast Cancer Treatment Decisions

    August 26th 2025, 8:00pm

    Video

    Dr. William Audeh explains how treatment decisions for breast cancer can be informed by a patient’s ultra-low, low or high genomic risk status.

    Non-Drug Therapies and Support Improve Cancer Care Outcomes

    August 26th 2025, 7:00pm

    Article

    Non-drug therapies, counseling and telehealth improved pain, mood and communication in cancer care, though older adults and minorities remain underrepresented.

    One Stitch at a Time: Crocheting and Coping with a Cancer Diagnosis

    August 26th 2025, 5:00pm

    Article

    After an blood cancer diagnosis and stem cell transplant, I found purpose in crochet, turning fear into creativity and connection one stitch at a time.

    Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer

    August 26th 2025, 4:00pm

    Article

    Rina-S earned breakthrough therapy designation for patients with advanced endometrial cancer whose disease has worsened after platinum-based chemotherapy.

    FDA Grants Breakthrough Device Status to MRD Test in Colorectal Cancer

    August 26th 2025, 3:00pm

    Article

    The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for patients with stage 2 colorectal cancer after surgery.

    Why Patients With Cancer ‘Have to Be Our Own Advocates’

    August 26th 2025, 1:00pm

    Video

    Kristen Dahlgren of the Cancer Vaccine Coalition spoke with CURE about patients’ need to find reliable sources of information.